Journal Article

HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway

Zhang, Hui, Guo, Xiang-Yu, Zhao, Rui-Nan, Shi, Duan-Bo, Ma, Ran-Ran, He, Jun-Yi, Gao, Peng, Hou, Feng

2023

Overview

Background Gastric cancer is the fourth leading cause of cancer-related deaths worldwide. And patient outcomes are poor due to tumor relapse and metastasis. To develop new therapeutic strategies, it is of great importance to explore the mechanism underlying the progression of gastric cancer. Methods Primary gastric cancer samples with lymph node metastases (LNM) and without LNM were subjected to mRNA microarray assay. The differentially expressed genes were confirmed by RT-qPCR. HRCT1 protein expression was further detected using an immunohistochemistry (IHC) assay. In vitro and in vivo assays were performed to investigate the role of HRCT1 in tumor invasion, metastasis, and proliferation. The expressions of the downstream target genes of HRCT1 were detected by microarray, RT-qPCR and Western blot assays. Dual-luciferase reporter and Western blot assays were carried out to identify miRNAs target to HRCT1. Results HRCT1 was upregulated in gastric cancer, and high expression of HRCT1 was associated with poor overall survival (OS) and disease-free survival (DFS). Moreover, HRCT1protein expression was an independent predictor for poor OS and DFS. HRCT1 could promote gastric cancer cells’ migration, invasion, and proliferation in vitro as well as tumor metastasis and growth in vivo. Notably, our data showed that HRCT1 promoted gastric cancer progression by activating the ERBB2-MAPK signaling pathway. At least partially, the expression of HRCT1 could be negatively regulated by miR-124-3p. Conclusions The upregulated expression of HRCT1 predicts poor survival for patients with gastric cancer. HRCT1 promotes tumor progression by activating the ERBB2-MAPK pathway. HRCT1, negatively regulated by miR-124-3p, may be a potential therapeutic target for patients with gastric cancer.

• Publisher: Springer Nature Singapore,Springer Nature B.V
• Subject: Abdominal Surgery / Binding sites / Cancer Research / Cell Line, Tumor / Cell migration / Cell Movement - genetics / Cell proliferation / Cell Proliferation - genetics / Disease / ErbB-2 protein / Gastric cancer / Gastroenterology / Gene Expression Regulation, Neoplastic / Genes / Humans / Immunohistochemistry / Investigations / Lymph nodes / Lymphatic Metastasis / MAP kinase / Medical prognosis / Medicine / Medicine & Public Health / Metastases / Metastasis / MicroRNAs / MicroRNAs - genetics / mRNA / Oncology / Original Article / Proteins / Receptor, ErbB-2 - metabolism / Signal Transduction / Stomach Neoplasms - pathology / Surgical Oncology / Survival analysis / Therapeutic targets / Tumors